Cytokinetics announced that it is joining the European Organisation for Rare Diseases and the National Organization for Rare Disorders to recognize Rare Disease Day on February 28, 2023. Rare Disease Day is an international campaign elevating the awareness and public understanding of rare diseases. The initiative spotlights the more than 300 million people worldwide living with a rare disease, and the awareness efforts focused on bringing them more equitable access to diagnosis, treatment, care and social opportunity.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CYTK:
- Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
- Cytokinetics management to meet with Cantor Fitzgerald
- Cytokinetics initiated with a Neutral at BofA
- Cytokinetics to Announce Fourth Quarter Results on March 1, 2023
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)